Wnt5a and Planar Cell Polarity in Kidney Development and Cyst formation

Wnt5a 和平面细胞极性在肾脏发育和囊肿形成中的作用

基本信息

  • 批准号:
    8383256
  • 负责人:
  • 金额:
    $ 15.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-15 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Congenital anomalies of the kidney and urinary tract (CAKUT) constitutes 20-30% of anomalies identified in the prenatal period, and is estimated to play a causative role in up to 50% of cases of end-stage kidney disease in children. CAKUT, affecting approximately 600,000 Americans, encompases a large group of disorders that result from abnormal renal developmental processes. Planar cell polarity (PCP) is the coordinated orientation of cells and cellular structures along an axis within the plane of an epithelial surfac. PCP plays a central role during renal development when newly formed tubules undergo progressive lengthening by directed cell migration and cell division. Wnt family proteins have been shown to control cell polarity and directional cell movement in many developmental systems. The mechanisms by which Wnt signaling pathways integrate the organization of receptors, organelles, and cytoskeletal proteins to confer cell polarity and directional cell movement are not completely understood. The goal here is to understand the mechanism by which Wnt5a integrates downstream organelles and cytoskeletal proteins, as well as PCP proteins, to confer cell polarity and directional cell movement during kidney development. Wnt5a is a noncanonical Wnt that binds to its receptor Frizzled, acts through disheveled (Dsh), and activates both the Wnt/Ca2+ and PCP pathways. I previously showed that Wnt5a nul mice develop defects in prostate gland lumenization and planar cell polarity, and Wnt5a null mice, which die at birth, lack kidneys. Wnt5a appears to be expressed in the mesenchyme/stroma of the developing mouse kidney. The hypothesis, therefore, that we propose testing is that Wnt5a regulates kidney development via actions on the PCP pathway. Accordingly, in Aim 1, I will use in vitro cel culture to investigate the detailed mechanism by which Wnt5a regulates PCP. In Aim 2, I will determine the in vivo role of Wnt5a signaling for guiding pronephric kidney development, using antisense Wnt5a morpholinos in zebrafish. Use of zebrafish will allow me to rapidly confirm and expand on the mechanistic in vitro results from Aim 1. Finally, in Aim 3, I will determine the role of Wnt5a in controlling PCP and regulating metanephric kidney development in vivo by utilizing the Cre/loxP binary mouse system to generate kidney-specific Wnt5a knockout mice. Wnt5a floxed mice are available to us and I plan to do a whole expression profile of Wnt5a in the developing mouse kidney to confirm reports of Wnt5a expression in developing kidney mesenchyme/stroma. Mesenchymal kidney Cre drivers, such as FoxD1, are commercially available, and I can knockout Wnt5a in both a kidney-specific and temporal manner by mating Wnt5a floxed mice with FoxD1-CreERT2 mice. I will evaluate oriented cell division and other PCP parameters in the Wnt5a knockout model and then investigate downstream elements including PCP proteins. Successful completion of these experiments will result in the identification of novel candidate targets for therapeutic intervention in CAKUT, a disorder for which no approved treatments currently exist. PUBLIC HEALTH RELEVANCE: Congenital anomalies of the kidney and urinary tract (CAKUT) constitute 20-30% of all birth defects identified in newborns, and is the cause of up to 50% of childhood end-stage kidney disease. Wnt5a is a member of the Wnt gene family, a group of very important developmental genes, and mice without Wnt5a lack kidneys. The proposed experiments are designed to determine the mechanism by which Wnt5a regulates kidney development, with the successful completion of these experiments resulting in the identification of novel candidate targets for therapeutic intervention in CAKUT, a disorder for which no treatments currently exist.
描述(由申请人提供):肾脏和尿路(Cakut)的先天性异常占产前时期鉴定的异常的20-30%,据估计,在儿童的最终末期肾脏病病例中最多可在50%的病例中起致病作用。卡库特(Cakut)影响了大约60万美国人,它包含了由于肾脏发育过程异常而导致的大量疾病。平面细胞极性(PCP)是沿上皮表面平面内轴的细胞和细胞结构的协调方向。当新形成的小管通过定向细胞迁移和细胞分裂进行逐步延长时,PCP在肾发育过程中起着核心作用。 Wnt家族蛋白已显示可控制许多发育系统中的细胞极性和定向细胞运动。 Wnt信号通路整合受体,细胞器和细胞骨架蛋白的组织以赋予细胞极性和定向细胞运动的机制。这里的目的是了解WNT5A整合下游细胞器和细胞骨架蛋白以及PCP蛋白的机制,以在肾脏发育过程中赋予细胞极性和方向性细胞运动。 Wnt5a是一种非规范的Wnt,与其受体卷曲结合,通过衣衫e(DSH)起作用,并激活Wnt/Ca2+和PCP途径。我先前表明,wnt5a小鼠在前列腺透明度和平面细胞极性中出现缺陷,而生于出生时死亡的Wnt5a无效小鼠缺乏肾脏。 Wnt5a似乎在发育中的小鼠肾脏的间充质/基质中表达。因此,我们提出的测试的假设是WNT5A通过在PCP途径上的作用来调节肾脏发育。因此,在AIM 1中,我将使用体外培养物来研究WNT5A调节PCP的详细机制。在AIM 2中,我将使用反义WNT5A吗磷脂在斑马鱼中确定Wnt5a信号传导在引导倾斜肾脏发育中的体内作用。斑马鱼的使用将使我能够迅速确认和扩展AIM 1的体外结果。最后,在AIM 3中,我将确定Wnt5a在控制PCP和调节体内跨肾上腺素肾脏发育中的作用,通过使用CRE/LOXP二进制型二进制型肾小管型肾脏型肾小管肾脏特异性Wnt​​ney Wntney Wntney Wnt5A敲除小鼠。我们可以使用Wnt5a Floxed小鼠,我计划在发育中的小鼠肾脏中进行WNT5A的全面表达曲线,以确认在发育中的肾脏间充质/基质中的Wnt5a表达的报道。诸如FOXD1之类的间充质肾脏CRE驱动器是可商购的,我可以通过将Wnt5a Floxed小鼠与FoxD1-Creert2小鼠交配,以肾脏特异性和时间的方式敲除Wnt5a。我将评估Wnt5a基因敲除模型中的定向细胞分裂和其他PCP参数,然后研究包括PCP蛋白在内的下游元素。这些实验的成功完成将导致确定在Cakut治疗干预措施的新型候选靶标,该疾病目前尚无批准的治疗方法。 公共卫生相关性:肾脏和尿路的先天异常(Cakut)占新生儿中所有出生缺陷的20-30%,是童年末期肾脏疾病的50%的原因。 Wnt5a是Wnt Gene家族的成员,Wnt Gene家族是一组非常重要的发育基因,而没有Wnt5a的小鼠缺乏肾脏。提出的实验旨在确定WNT5A调节肾脏发育的机制,这些实验成功地完成了这些实验,从而确定了Cakut治疗干预的新型候选靶标,这是当前不存在治疗的疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Liwei Huang其他文献

Liwei Huang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Liwei Huang', 18)}}的其他基金

Wnt5a and Planar Cell Polarity in Kidney Development and Cyst formation
Wnt5a 和平面细胞极性在肾脏发育和囊肿形成中的作用
  • 批准号:
    8848816
  • 财政年份:
    2012
  • 资助金额:
    $ 15.51万
  • 项目类别:
Wnt5a and Planar Cell Polarity in Kidney Development and Cyst formation
Wnt5a 和平面细胞极性在肾脏发育和囊肿形成中的作用
  • 批准号:
    8505479
  • 财政年份:
    2012
  • 资助金额:
    $ 15.51万
  • 项目类别:
Wnt5a and Planar Cell Polarity in Kidney Development and Cyst formation
Wnt5a 和平面细胞极性在肾脏发育和囊肿形成中的作用
  • 批准号:
    9028609
  • 财政年份:
    2012
  • 资助金额:
    $ 15.51万
  • 项目类别:
Wnt5a and Planar Cell Polarity in Kidney Development and Cyst formation
Wnt5a 和平面细胞极性在肾脏发育和囊肿形成中的作用
  • 批准号:
    8694353
  • 财政年份:
    2012
  • 资助金额:
    $ 15.51万
  • 项目类别:

相似海外基金

Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 15.51万
  • 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
  • 批准号:
    10678341
  • 财政年份:
    2023
  • 资助金额:
    $ 15.51万
  • 项目类别:
Robust Precision Mapping of Cortical and Subcortical Brain Metabolic Signatures in AD
AD 中大脑皮层和皮层下代谢特征的稳健精确绘图
  • 批准号:
    10746348
  • 财政年份:
    2023
  • 资助金额:
    $ 15.51万
  • 项目类别:
A mechanistic understanding of glymphatic transport and its implications in neurodegenerative disease
对类淋巴运输的机制及其在神经退行性疾病中的影响的理解
  • 批准号:
    10742654
  • 财政年份:
    2023
  • 资助金额:
    $ 15.51万
  • 项目类别:
Cellular Basis for Autonomic Regulation of Cardiac Arrhythmias
心律失常自主调节的细胞基础
  • 批准号:
    10627578
  • 财政年份:
    2023
  • 资助金额:
    $ 15.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了